• Patrick Fleming, Yue Bo Yang, Charles Lynde, Braden O'Neill, and Kyle O Lee.
• From Division of Dermatology, University of Toronto, Toronto, ON, Canada (PF, CL); MD Program, University of British Columbia, Vancouver, BC, Canada (YBY); Department of Family and Community Medicine, North York General Hospital, Toronto, ON, Canada (BO); Department of Family and Community Medicine, St. Michael's Hospital, Toronto, ON, Canada (KOL).
• J Am Board Fam Med. 2020 Jul 1; 33 (4): 626-635.

ObjectiveTo provide primary care providers an up-to-date approach to the diagnosis and management of atopic dermatitis (AD).Quality Of EvidencePubMed, Cochrane, and MEDLINE databases were searched for relevant meta-analyses, randomized controlled trials, systematic reviews, and observational studies about the diagnosis and management of AD.Main MessageAD is a common chronic skin disease characterized by immune dysregulation and skin barrier dysfunction. It has a substantial impact on quality of life across all ages. Despite this, AD is often still undertreated due to inaccurate diagnoses, even by many experienced dermatologists. Many primary care providers may not be aware of its commonly associated medical and psychiatric comorbidities or be familiar with new treatment options.ConclusionIn this clinical review, we describe the pathophysiology, epidemiology, diagnosis, and treatment of AD, specifically highlighting commonly used therapies and novel medications.© Copyright 2020 by the American Board of Family Medicine.

17 keywords...

hide…